{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T08:26:03Z","timestamp":1793175963094,"version":"4.5.0"},"reference-count":199,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,5]],"date-time":"2025-07-05T00:00:00Z","timestamp":1751673600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012190","name":"Ministry of Science and Higher Education of the Russian Federation","doi-asserted-by":"publisher","award":["075-10-2025-017"],"award-info":[{"award-number":["075-10-2025-017"]}],"id":[{"id":"10.13039\/501100012190","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012190","name":"Ministry of Science and Higher Education of the Russian Federation","doi-asserted-by":"publisher","award":["27.02.2025"],"award-info":[{"award-number":["27.02.2025"]}],"id":[{"id":"10.13039\/501100012190","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.ejmech.2025.117935","type":"journal-article","created":{"date-parts":[[2025,7,5]],"date-time":"2025-07-05T18:32:56Z","timestamp":1751740376000},"page":"117935","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"special_numbering":"C","title":["1,2,4-Oxadiazoles in medicinal chemistry: trends of the last years"],"prefix":"10.1016","volume":"297","author":[{"given":"Anastasia","family":"Cherkasova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Astolfi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxim","family":"Nawrozkij","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boris","family":"Gladkikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonora","family":"Proia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lidia","family":"Giuliani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dante","family":"Rotili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5399-975X","authenticated-orcid":false,"given":"Rino","family":"Ragno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roman","family":"Ivanov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2025.117935_bib1","doi-asserted-by":"crossref","first-page":"3674","DOI":"10.1016\/j.bmcl.2017.07.015","article-title":"Synthesis and in vitro antiproliferative activities of (5-aryl-1,2,4-oxadiazole-3-yl) methyl d-ribofuranosides","volume":"27","author":"Avanzo","year":"2017","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2025.117935_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.phytochem.2022.113259","article-title":"Antitumoral activity of 1,2,4-oxadiazoles compounds isolated from the Neowerdermannia vorwerkii in liver and colon human cancer cells","volume":"201","author":"Apaza Ticona","year":"2022","journal-title":"Phytochemistry"},{"key":"10.1016\/j.ejmech.2025.117935_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.cdc.2022.100861","article-title":"Synthesis, characterization, biological evaluation and molecular docking of novel amide derivatives of indole-1,2,4-oxadiazole clubbed thiazoles","volume":"39","author":"Yenireddy","year":"2022","journal-title":"Chem. Data Collect."},{"key":"10.1016\/j.ejmech.2025.117935_bib4","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1039\/D4MD00055B","article-title":"Computational design, synthesis, and assessment of 3-(4-(4-(1,3,4-oxadiazol-2-yl)-1H-imidazole-2-yl)phenyl)-1,2,4-oxadiazole derivatives as effective epidermal growth factor receptor inhibitors: a prospective strategy for anticancer therapy","volume":"15","author":"Khedkar","year":"2024","journal-title":"RSC Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117935_bib5","doi-asserted-by":"crossref","first-page":"3472","DOI":"10.2174\/0929867329666220929145619","article-title":"Oxadiazole derivatives as anticancer and immunomodulatory agents: a systematic review","volume":"30","author":"Ara\u00fajo","year":"2023","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117935_bib6","doi-asserted-by":"crossref","DOI":"10.1002\/cbdv.202300466","article-title":"Design, synthesis, anticancer evaluation, and molecular docking studies of oxazole-incorporated naphthyridine derivatives","volume":"20","author":"Rangaswamy","year":"2023","journal-title":"Chem. Biodivers."},{"key":"10.1016\/j.ejmech.2025.117935_bib7","doi-asserted-by":"crossref","DOI":"10.1002\/jhet.4859","article-title":"Synthesis of novel pyrido[3,4\u2010d]pyrimidine\u2010thiazolidione\u20101,2,4\u2010oxadiazoles as potent EGFR targeting anticancer agents","author":"Varaprasadu","year":"2024","journal-title":"J. Heterocycl. Chem."},{"key":"10.1016\/j.ejmech.2025.117935_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2022.115198","article-title":"Anti-inflammatory properties of Neowerdermannia vorwerkii Fri\u010d \u201cAchacana\u201d used in treating stomach-related ailments","volume":"292","author":"Apaza Ticona","year":"2022","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.ejmech.2025.117935_bib9","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1007\/s11030-022-10536-z","article-title":"Exploration of NMI-MsCl mediated amide bond formation for the synthesis of novel 3,5-substituted-1,2,4-oxadiazole derivatives: synthesis, evaluation of anti-inflammatory activity and molecular docking studies","volume":"27","author":"Kulkarni","year":"2023","journal-title":"Mol. Divers."},{"key":"10.1016\/j.ejmech.2025.117935_bib10","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.2174\/1389557518666180524112050","article-title":"1,2,4-Oxadiazole as a privileged scaffold for anti-inflammatory and analgesic activities: a review","volume":"18","author":"Chawla","year":"2018","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117935_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.104885","article-title":"Novel 1,2,4-oxadiazole-chalcone\/oxime hybrids as potential antibacterial DNA gyrase inhibitors: design, synthesis, ADMET prediction and molecular docking study","volume":"111","author":"Ibrahim","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.117935_bib12","doi-asserted-by":"crossref","first-page":"6","DOI":"10.22571\/2526-4338555","article-title":"S\u00edntese, caracteriza\u00e7\u00e3o e avalia\u00e7\u00e3o antimicrobiana de 1,2,4-oxadiaz\u00f3is derivados do \u00e1cido trans-3,4-(metilenodioxi)-cin\u00e2mico","volume":"6","author":"De Freitas Filho","year":"2022","journal-title":"Acta Bras."},{"key":"10.1016\/j.ejmech.2025.117935_bib13","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1080\/14756366.2021.1900162","article-title":"In vitro anti-TB properties, in silico target validation, molecular docking and dynamics studies of substituted 1,2,4-oxadiazole analogues against Mycobacterium tuberculosis","volume":"36","author":"Deb","year":"2021","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117935_bib14","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1007\/s00044-020-02505-8","article-title":"Design, synthesis, and characterization of novel substituted 1,2,4-oxadiazole and their biological broadcast","volume":"29","author":"Parikh","year":"2020","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ejmech.2025.117935_bib15","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1007\/s00436-022-07554-z","article-title":"Antiparasitary and antiproliferative activities in vitro of a 1,2,4-oxadiazole derivative on Trypanosoma cruzi","volume":"121","author":"Rocha","year":"2022","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.ejmech.2025.117935_bib16","article-title":"A novel protocol for the synthesis of 1,2,4-Oxadiazoles active against trypanosomatids and drug-resistant leukemia cell lines","volume":"7","author":"Pitasse-Santos","year":"2022","journal-title":"Trop. Med. Infect. Dis."},{"key":"10.1016\/j.ejmech.2025.117935_bib17","doi-asserted-by":"crossref","first-page":"943062","DOI":"10.3389\/fchem.2022.943062","article-title":"Design, synthesis, and biological activity of novel chalcone derivatives containing an 1,2,4-Oxadiazole moiety","volume":"10","author":"Luo","year":"2022","journal-title":"Front. Chem."},{"key":"10.1016\/j.ejmech.2025.117935_bib18","first-page":"435","article-title":"1,2,4- and 1,3,4-Oxadiazoles as scaffolds in the development of antiparasitic agents","volume":"29","author":"Pitasse-Santos","year":"2018","journal-title":"J. Braz. Chem. Soc."},{"key":"10.1016\/j.ejmech.2025.117935_bib19","first-page":"1390","article-title":"Design, synthesis and anti-fungal activity of 1, 2, 4-oxadiazole derivatives","volume":"74","author":"Wang","year":"2023","journal-title":"CIE J."},{"key":"10.1016\/j.ejmech.2025.117935_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.indcrop.2022.115087","article-title":"Non-food bioactive products: diversified invention of 1,2,4-oxadiazole-containing amide derivatives for novel fungicidal candidate discovery","volume":"184","author":"Hu","year":"2022","journal-title":"Ind. Crops Prod."},{"key":"10.1016\/j.ejmech.2025.117935_bib21","article-title":"Novel 2-(Diphenylmethylidene) malonic acid derivatives as Anti-HIV agents: molecular modeling, synthesis and biological evaluation","volume":"21","author":"Lotfaliei","year":"2022","journal-title":"Iran. J. Pharm. Res. (IJPR)"},{"key":"10.1016\/j.ejmech.2025.117935_bib22","first-page":"2967","article-title":"A review on synthetic account of 1,2,4-oxadiazoles as","volume":"26","author":"Dhameliya","year":"2022","journal-title":"Anti-Infect. Agents"},{"key":"10.1016\/j.ejmech.2025.117935_bib23","doi-asserted-by":"crossref","DOI":"10.59761\/RCR5109","article-title":"Energetic 1,2,4-oxadiazoles: synthesis and properties","volume":"93","author":"Shaferov","year":"2024","journal-title":"Russ. Chem. Rev."},{"key":"10.1016\/j.ejmech.2025.117935_bib24","series-title":"Bioisosteres in Medicinal Chemistry","author":"Brown","year":"2012"},{"key":"10.1016\/j.ejmech.2025.117935_bib25","doi-asserted-by":"crossref","DOI":"10.1002\/cmdc.202200638","article-title":"Bioisosterism: 1,2,4-oxadiazole rings","volume":"18","author":"Camci","year":"2023","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2025.117935_bib26","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1021\/jm00008a014","article-title":"Picornavirus inhibitors: Trifluoromethyl substitution provides a global protective effect against hepatic metabolism","volume":"38","author":"Diana","year":"1995","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117935_bib27","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1476-5381.1961.tb01080.x","article-title":"Pharmacological properties of 3-phenyl-5beta diethylaminoethyl-1,2,4-oxadiazole","volume":"16","author":"Silvestrini","year":"1961","journal-title":"Br. J. Pharmacol. Chemother."},{"key":"10.1016\/j.ejmech.2025.117935_bib28","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0021-5198(19)36217-1","article-title":"Preventive action of proxazole in experimentally induced renal hypertension in rats","volume":"21","author":"Burberi","year":"1971","journal-title":"Jpn. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.117935_bib29","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s40262-012-0024-7","article-title":"Pharmacokinetics, pharmacodynamics and tolerability of opicapone, a novel Catechol-O-Methyltransferase inhibitor, in healthy subjects","volume":"52","author":"Almeida","year":"2013","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ejmech.2025.117935_bib30","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1093\/jac\/dkq198","article-title":"ASP2151, a novel helicase\u2013primase inhibitor, possesses antiviral activity against varicella\u2013zoster virus and herpes simplex virus types 1 and 2","volume":"65","author":"Chono","year":"2010","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ejmech.2025.117935_bib31","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1111\/bph.13476","article-title":"Ozanimod (RPC1063) is a potent sphingosine-1-phosphate receptor-1 (S1P1) and receptor-5 (S1P5) agonist with autoimmune disease-modifying activity","volume":"173","author":"Scott","year":"2016","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.117935_bib32","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/S0140-6736(17)31611-2","article-title":"Ataluren in patients with nonsense mutation Duchenne muscular dystrophy (ACT DMD): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial","volume":"390","author":"McDonald","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.ejmech.2025.117935_bib33","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/j.2042-7158.1969.tb08294.x","article-title":"Effect of aminophylline, butalamine and imolamine on human isolated smooth muscle","volume":"21","author":"Coupar","year":"1969","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.117935_bib34","doi-asserted-by":"crossref","first-page":"111","DOI":"10.3390\/ph13060111","article-title":"Novel 1,2,4-Oxadiazole derivatives in drug discovery","volume":"13","author":"Biernacki","year":"2020","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ejmech.2025.117935_bib35","article-title":"A comprehensive review of recent advances in the biological activities of 1,2,4\u2010oxadiazoles","volume":"355","author":"Omnia","year":"2022","journal-title":"Arch. Pharm."},{"key":"10.1016\/j.ejmech.2025.117935_bib36","doi-asserted-by":"crossref","first-page":"3489","DOI":"10.1007\/s00253-022-11969-0","article-title":"Biological activity of oxadiazole and thiadiazole derivatives","volume":"106","author":"Atmaram","year":"2022","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.ejmech.2025.117935_bib37","doi-asserted-by":"crossref","first-page":"2200123","DOI":"10.1002\/ardp.202200123","article-title":"A highly versatile scaffold in drug discovery","volume":"355","author":"Desai","year":"2022","journal-title":"Arch. Pharm."},{"key":"10.1016\/j.ejmech.2025.117935_bib38","doi-asserted-by":"crossref","first-page":"90","DOI":"10.2174\/2589977512666201221162627","article-title":"Significance of 1,3,4-Oxadiazole containing compounds in new drug development","volume":"13","author":"Rana","year":"2021","journal-title":"Curr. Drug. Res. Rev."},{"key":"10.1016\/j.ejmech.2025.117935_bib39","first-page":"663","volume":"20","author":"Chaudhary","year":"2023","journal-title":"Recent Adv. Synthes.Bioactiv.1,3,4-Oxadiaz."},{"key":"10.1016\/j.ejmech.2025.117935_bib40","doi-asserted-by":"crossref","first-page":"4583","DOI":"10.1021\/acs.jmedchem.3c01984","article-title":"Design and synthesis of 3-(2H-chromen-3-yl)-5-aryl-1,2,4-oxadiazole derivatives as novel toll-like receptor 2\/1 agonists that inhibit lung cancer in vitro and in vivo","volume":"67","author":"Wang","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117935_bib41","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.1134\/S1070363222110196","article-title":"Synthesis of chromene based 1,2,4-Oxadiazoles: in vitro anticancer, molecular docking, and ADMET studies","volume":"92","author":"Vidya","year":"2022","journal-title":"Russ. J. Gen. Chem."},{"key":"10.1016\/j.ejmech.2025.117935_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115907","article-title":"5-(Trifluoromethyl)-1,2,4-oxadiazole (TFMO)-based highly selective class IIa HDAC inhibitors exhibit synergistic anticancer activity in combination with bortezomib","volume":"263","author":"Asfaha","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117935_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.114011","article-title":"Design, synthesis, biochemical evaluation, radiolabeling and in vivo imaging with high affinity class-IIa histone deacetylase inhibitor for molecular imaging and targeted therapy","volume":"228","author":"Turkman","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117935_bib44","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1080\/00397911.2023.2282599","article-title":"Design, synthesis, anticancer evaluation and molecular docking studies of 1,2,4-oxadiazole incorporated indazole-isoxazole derivatives","volume":"54","author":"Lingam","year":"2024","journal-title":"Synth. Commun."},{"key":"10.1016\/j.ejmech.2025.117935_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.rechem.2022.100649","article-title":"Synthesis and biological evaluation of aryl 1,2,4-oxadiazole incorporated (2-(oxazol)-1H-imidazoles as anticancer agents","volume":"4","author":"Bairi","year":"2022","journal-title":"Results Chem."},{"key":"10.1016\/j.ejmech.2025.117935_bib46","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1080\/00397911.2023.2287796","article-title":"Design, synthesis, and characterization of 3-(2-(pyrimidin-5-yl)thiazol-4-yl)-1,2,4-oxadiazole derivatives: anticancer and molecular docking investigations","volume":"54","author":"Khedkar","year":"2024","journal-title":"Synth. Commun."},{"key":"10.1016\/j.ejmech.2025.117935_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.107029","article-title":"Synthesis, molecular docking and biological evaluation of 1,2,4-oxadiazole based novel non-steroidal derivatives against prostate cancer","volume":"143","author":"Kumar","year":"2024","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.117935_bib48","doi-asserted-by":"crossref","first-page":"10622","DOI":"10.1021\/acs.jmedchem.4c00080","article-title":"Discovery of 5-(Piperidin-4-yl)-1,2,4-oxadiazole derivatives as a new class of human caseinolytic protease P agonists for the treatment of hepatocellular carcinoma","volume":"67","author":"Liu","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117935_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2024.138209","article-title":"Design and synthesis of some new imidazole-morpholine-1,2,4-oxadiazole hybrids as EGFR targeting in vitro anti-breast cancer agents","volume":"1310","author":"Kannekanti","year":"2024","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.ejmech.2025.117935_bib50","doi-asserted-by":"crossref","first-page":"2866","DOI":"10.1134\/S1070363223110178","article-title":"Synthesis of Indole-1,3,4-oxadiazole based sulfonyl 1,2,4-Oxadiazole derivatives as EGFR targeting anticancer agents","volume":"93","author":"Dubba","year":"2023","journal-title":"Russ. J. Gen. Chem."},{"key":"10.1016\/j.ejmech.2025.117935_bib51","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1134\/S1070363222010169","article-title":"Design, synthesis, and anti-proliferative activity of quinoxaline linked 1,2,4-Oxadiazole hybrids","volume":"92","author":"Badithapuram","year":"2022","journal-title":"Russ. J. Gen. Chem."},{"key":"10.1016\/j.ejmech.2025.117935_bib52","doi-asserted-by":"crossref","first-page":"9175","DOI":"10.1080\/10406638.2022.2158884","article-title":"One-pot synthesis of some new Phthalazine-Piperazine-1,2,4-Oxadiazole hybrids: anticancer evaluation, molecular docking and ADMET studies","volume":"43","author":"Samala","year":"2023","journal-title":"Polycycl. Aromat. Compd."},{"key":"10.1016\/j.ejmech.2025.117935_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.tet.2022.132991","article-title":"New molecular hybrids containing benzimidazole, thiazolidine-2,4-dione and 1,2,4-oxadiazole as EGFR directing cytotoxic agents","volume":"124","author":"Venu","year":"2022","journal-title":"Tetrahedron"},{"key":"10.1016\/j.ejmech.2025.117935_bib54","doi-asserted-by":"crossref","DOI":"10.1002\/slct.202200972","article-title":"One\u2010pot synthesis of some new isatin\u20101,2,4\u2010oxadiazole hybrids as VEGFR\u20102 aiming anticancer agents","volume":"7","author":"Boda","year":"2022","journal-title":"ChemistrySelect"},{"key":"10.1016\/j.ejmech.2025.117935_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2023.117441","article-title":"Design, synthesis, antitumor activity, and molecular dynamics simulations of novel sphingosine kinase 2 inhibitors","volume":"93","author":"Wang","year":"2023","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117935_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115918","article-title":"Design and synthesis of certain 7-Aryl-2-Methyl-3-Substituted Pyrazolo{1,5-a}Pyrimidines as multikinase inhibitors","volume":"262","author":"Al-Qadhi","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117935_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.cdc.2023.101036","article-title":"Synthesis and biological evaluation of novel amide derivatives of 1,2,4-oxadiazole-imidazopyridines as anticancer agents","volume":"46","author":"Boddiboyena","year":"2023","journal-title":"Chem. Data Collect."},{"key":"10.1016\/j.ejmech.2025.117935_bib58","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.mencom.2024.02.032","article-title":"Novel 2-amino-substituted (thio)morpholine-3,5-diones: synthesis and cytotoxicity studies","volume":"34","author":"Kasparavichius","year":"2024","journal-title":"Mendeleev Commun."},{"key":"10.1016\/j.ejmech.2025.117935_bib59","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.1021\/acs.jmedchem.2c01591","article-title":"Discovery of 2-(3-Benzamidopropanamido)thiazole-5-carboxylate inhibitors of the Kinesin HSET (KIFC1) and the development of cellular target engagement probes","volume":"66","author":"Saint-Dizier","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117935_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114904","article-title":"2-Phenoxy-3, 4\u2019-bipyridine derivatives inhibit AURKB-dependent mitotic processes by disrupting its localization","volume":"245","author":"Lv","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117935_bib61","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1007\/s11172-023-3944-5","article-title":"Synthesis of [4-(3-aryl-1,2,4-oxadiazol-5-ylmethylthio)-2-methylphenoxy]acetic acids as new potential PPAR agonists","volume":"72","author":"Minin","year":"2023","journal-title":"Russ. Chem. Bull."},{"key":"10.1016\/j.ejmech.2025.117935_bib62","doi-asserted-by":"crossref","DOI":"10.1002\/aoc.7142","article-title":"Syntheses, characterizations, and Hirshfeld analysis of Ag(I) and Cu(II) complexes: a novel potent Ag(I)-based oxadiazole anticancer agent","volume":"37","author":"Ayoup","year":"2023","journal-title":"Appl. Organomet. Chem."},{"key":"10.1016\/j.ejmech.2025.117935_bib63","article-title":"Design, synthesis, and structure-activity studies of new rhodanine derivatives as carbonic anhydrase II, IX inhibitors","volume":"356","author":"Chinchilli","year":"2023","journal-title":"Arch. Pharm."},{"key":"10.1016\/j.ejmech.2025.117935_bib64","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202200019","article-title":"Design, synthesis, SAR, and biological evaluation of saccharin-based hybrids as carbonic anhydrase inhibitors","volume":"355","author":"Chinchilli","year":"2022","journal-title":"Arch. Pharm."},{"key":"10.1016\/j.ejmech.2025.117935_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114865","article-title":"Nature-inspired new isoindole-based Passerini adducts as efficient tumor-selective apoptotic inducers via caspase-3\/7 activation","volume":"245","author":"Ayoup","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117935_bib66","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1021\/acs.jmedchem.1c01509","article-title":"Discovery and lead optimization of Benzene-1,4-disulfonamides as oxidative phosphorylation inhibitors","volume":"65","author":"Xue","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117935_bib67","doi-asserted-by":"crossref","first-page":"15487","DOI":"10.1021\/acs.jmedchem.2c01554","article-title":"Discovery of a highly potent and orally bioavailable STAT3 dual phosphorylation inhibitor for pancreatic cancer treatment","volume":"65","author":"He","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117935_bib68","doi-asserted-by":"crossref","first-page":"12650","DOI":"10.1021\/acs.jmedchem.2c00413","article-title":"Discovery of a novel potent STAT3 inhibitor HP590 with dual p-Tyr705\/Ser727 inhibitory activity for gastric cancer treatment","volume":"65","author":"He","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117935_bib69","doi-asserted-by":"crossref","first-page":"20815","DOI":"10.1021\/jacs.2c08770","article-title":"Low-molecular weight small molecules can potently bind RNA and affect oncogenic pathways in cells","volume":"144","author":"Suresh","year":"2022","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2025.117935_bib70","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27010019","article-title":"A new oxadiazole-based Topsentin derivative modulates cyclin-dependent kinase 1 expression and exerts cytotoxic effects on pancreatic cancer cells","volume":"27","author":"Pecoraro","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2025.117935_bib71","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27010072","article-title":"New deoxycholic acid derived Tyrosyl-DNA phosphodiesterase 1 inhibitors also inhibit Tyrosyl-DNA phosphodiesterase 2","volume":"27","author":"Salomatina","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2025.117935_bib72","doi-asserted-by":"crossref","first-page":"3357","DOI":"10.1007\/s11030-021-10367-4","article-title":"Oxadiazol-based mTOR inhibitors with potent antiproliferative activities: synthetic and computational modeling","volume":"26","author":"Khanfar","year":"2022","journal-title":"Mol. Divers."},{"key":"10.1016\/j.ejmech.2025.117935_bib73","doi-asserted-by":"crossref","first-page":"14614","DOI":"10.1021\/acs.jmedchem.2c01120","article-title":"Fragment optimization of reversible binding to the switch II pocket on KRAS leads to a potent, in vivo active KRASG12C inhibitor","volume":"65","author":"Br\u00f6ker","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117935_bib74","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2021.132218","article-title":"Design and synthesis of new triarylimidazole derivatives as dual inhibitors of BRAFV600E\/p38\u03b1 with potential antiproliferative activity","volume":"1253","author":"Youssif","year":"2022","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.ejmech.2025.117935_bib75","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.55730\/1300-0527.3417","article-title":"Synthesis of novel oxadiazole derivatives and their cytotoxic activity against various cancer cell lines","volume":"46","author":"Sucu","year":"2022","journal-title":"Turk. J. Chem."},{"key":"10.1016\/j.ejmech.2025.117935_bib76","doi-asserted-by":"crossref","DOI":"10.1016\/j.cdc.2022.100909","article-title":"Design, synthesis and anticancer evaluation of 1,2,4-oxadiazole incorporated structurally modified hippuric acid derivatives","volume":"41","author":"Vakiti","year":"2022","journal-title":"Chem. Data Collect."},{"issue":"6","key":"10.1016\/j.ejmech.2025.117935_bib77","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1021\/acs.jmedchem.6b01609","article-title":"Development of 1,2,4-Oxadiazoles as potent and selective inhibitors of the human deacetylase Sirtuin 2: structure-activity relationship, X-ray crystal structure, and anticancer activity","volume":"60","author":"Moniot","year":"2017","journal-title":"J. Med. Chem."},{"issue":"12","key":"10.1016\/j.ejmech.2025.117935_bib78","doi-asserted-by":"crossref","first-page":"10076","DOI":"10.1021\/acs.jmedchem.4c00229","article-title":"Structure-activity studies of 1,2,4-Oxadiazoles for the inhibition of the NAD(+)-dependent lysine deacylase sirtuin 2","volume":"67","author":"Colcerasa","year":"2024","journal-title":"J. Med. Chem."},{"issue":"15","key":"10.1016\/j.ejmech.2025.117935_bib79","doi-asserted-by":"crossref","first-page":"4377","DOI":"10.1021\/jm800639h","article-title":"Oxadiazole-carbonylaminothioureas as SIRT1 and SIRT2 inhibitors","volume":"51","author":"Huhtiniemi","year":"2008","journal-title":"J. Med. Chem."},{"issue":"3","key":"10.1016\/j.ejmech.2025.117935_bib80","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1002\/cmdc.202000752","article-title":"1,2,4-Oxadiazole topsentin analogs with antiproliferative activity against pancreatic cancer cells, targeting GSK3\u03b2 kinase","volume":"16","author":"Carbone","year":"2020","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2025.117935_bib81","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3390\/md17010035","article-title":"New 1,2,4-Oxadiazole nortopsentin derivatives with cytotoxic activity","volume":"17","author":"Cascioferro","year":"2019","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.ejmech.2025.117935_bib82","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25010096","article-title":"Novel hydroxamic acids containing aryl-substituted 1,2,4- or 1,3,4-Oxadiazole backbones and an investigation of their antibiotic potentiation activity","volume":"25","author":"Zhukovets","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2025.117935_bib83","first-page":"1","article-title":"Pyrazole linked-1,2,4-oxadiazole derivatives as potential pharmacological agent: design, synthesis and antimicrobial study","author":"Kulkarni","year":"2022","journal-title":"Polycycl. Aromat. Compd."},{"key":"10.1016\/j.ejmech.2025.117935_bib84","doi-asserted-by":"crossref","first-page":"S91","DOI":"10.1134\/S107036322414010X","article-title":"N-Arylamino-1,2,4-oxadiazol-5(4H)-ones: synthesis, luminescent, antibacterial, and antienteroviral properties","volume":"94","author":"Konstantinova","year":"2024","journal-title":"Russ. J. Gen. Chem."},{"key":"10.1016\/j.ejmech.2025.117935_bib85","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1002\/jhet.4642","article-title":"An efficient synthesis of new 3,5\u2010bis(2\u2010arylthiazol\u20104\u2010yl)\u20101,2,4\u2010oxadiazole derivatives and their antimicrobial evaluation","volume":"60","author":"Shaikh","year":"2023","journal-title":"J. Heterocycl. Chem."},{"key":"10.1016\/j.ejmech.2025.117935_bib86","doi-asserted-by":"crossref","DOI":"10.1002\/slct.202302360","article-title":"Synthesis of 1,2,4\u2010oxadiazole\u2010sulfonamide conjugates and their synergistic effect with Ampicillin as antimicrobial agents","volume":"8","author":"Habib","year":"2023","journal-title":"ChemistrySelect"},{"key":"10.1016\/j.ejmech.2025.117935_bib87","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2024.138246","article-title":"Design, synthesis and preliminary antibacterial evaluation of novel 1,3-benzoxazole\/carboximidamide- and 1,3-benzoxazole\/3-aryl-1,2,4-oxadiazole hybrids","volume":"1310","author":"Alsimaree","year":"2024","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.ejmech.2025.117935_bib88","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25010377","article-title":"Synthesis and antibacterial activity of Mono- and Bi-Cationic pyridinium 1,2,4-Oxadiazoles and triazoles","volume":"25","author":"Amata","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2025.117935_bib89","doi-asserted-by":"crossref","DOI":"10.1016\/j.arabjc.2021.103538","article-title":"Novel 1,2,4-oxadiazole\/pyrrolidine hybrids as DNA gyrase and topoisomerase IV inhibitors with potential antibacterial activity","volume":"15","author":"Frejat","year":"2022","journal-title":"Arab. J. Chem."},{"key":"10.1016\/j.ejmech.2025.117935_bib90","article-title":"Synthesis of new 3-(4-methyl-2-arylthiazol-5-yl)-5-aryl-1,2,4-oxadiazole derivatives as potential cytotoxic and antimicrobial agents","volume":"6","author":"Shaikh","year":"2022","journal-title":"Eur.J.Med.Chem.Rep."},{"key":"10.1016\/j.ejmech.2025.117935_bib91","doi-asserted-by":"crossref","first-page":"13891","DOI":"10.1021\/acs.jmedchem.3c01249","article-title":"A potent and narrow-spectrum antibacterial against Clostridioides difficile infection","volume":"66","author":"Qian","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117935_bib92","doi-asserted-by":"crossref","first-page":"6737","DOI":"10.1021\/acsomega.1c06294","article-title":"Development of 1,2,4-Oxadiazole antimicrobial agents to treat enteric pathogens within the gastrointestinal tract","volume":"7","author":"Pitcher","year":"2022","journal-title":"ACS Omega"},{"key":"10.1016\/j.ejmech.2025.117935_bib93","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1021\/acs.jmedchem.3c02064","article-title":"Discovery of unique bis-substituted aromatic amide derivatives as novel highly potent antibiotics for combating Methicillin-resistant Staphylococcus aureus (MRSA)","volume":"67","author":"Guo","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117935_bib94","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27196619","article-title":"Structural variations in the central heterocyclic scaffold of tripartite 2,6-Difluorobenzamides: influence on their antibacterial activity against MDR Staphylococcus aureus","volume":"27","author":"Barbier","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2025.117935_bib95","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115921","article-title":"Design and synthesis of etrasimod derivatives as potent antibacterial agents against Gram-positive bacteria","volume":"263","author":"Zore","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117935_bib96","doi-asserted-by":"crossref","first-page":"S101","DOI":"10.1134\/S1068162023010272","article-title":"Sulfonyl-Benzoxazole based 1,2,4-Oxadiazoles: synthesis, in vitro antibacterial, antibiofilm, and in Silico ADME studies","volume":"48","author":"Vidya","year":"2022","journal-title":"Russ. J. Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.117935_bib97","doi-asserted-by":"crossref","first-page":"101","DOI":"10.25303\/2607rjce101110","article-title":"Synthesis of new Oxadiazole derivatives containing 2H-chromen-2-one moiety: a novel class of potential antibacterial and antifungal agents","volume":"26","author":"Mahesh","year":"2022","journal-title":"Res. J. Chem. Environ."},{"key":"10.1016\/j.ejmech.2025.117935_bib98","article-title":"1,2,4-Oxadiazole topsentin analogs as staphylococcal biofilm inhibitors targeting the bacterial transpeptidase sortase A","volume":"209","author":"Parrino","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117935_bib99","article-title":"Benzamides substituted with quinoline-linked 1,2,4-Oxadiazole: synthesis, biological activity and toxicity to zebrafish embryo","volume":"27","author":"Sun","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2025.117935_bib100","article-title":"Design, synthesis and antifungal\/nematicidal activity of novel 1,2,4-Oxadiazole derivatives containing amide fragments","volume":"23","author":"Liu","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2025.117935_bib101","doi-asserted-by":"crossref","first-page":"23544","DOI":"10.1039\/D2RA04327K","article-title":"Synthesis, biological activity and toxicity to zebrafish of benzamides substituted with pyrazole-linked 1,2,4-oxadiazole","volume":"12","author":"Shao","year":"2022","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejmech.2025.117935_bib102","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27154692","article-title":"Structure-based bioisosterism design, synthesis, biological activity and toxicity of 1,2,4-Oxadiazole substituted benzamides analogues containing pyrazole rings","volume":"27","author":"Tu","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2025.117935_bib103","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1080\/00397911.2022.2039709","article-title":"Synthesis, characterization, and antifungal activity of novel chromene oxadiazole based dithiocarbamates","volume":"52","author":"Konda","year":"2022","journal-title":"Synth. Commun."},{"key":"10.1016\/j.ejmech.2025.117935_bib104","doi-asserted-by":"crossref","first-page":"15380","DOI":"10.1021\/acs.jmedchem.3c01514","article-title":"Identification and optimization of novel inhibitors of the polyketide synthase 13 thioesterase domain with antitubercular activity","volume":"66","author":"Green","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117935_bib105","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.105242","article-title":"Mycobacterium enoyl acyl carrier protein reductase (InhA): a key target for antitubercular drug discovery","volume":"115","author":"Prasad","year":"2021","journal-title":"Bioorg. Chem."},{"issue":"4","key":"10.1016\/j.ejmech.2025.117935_bib106","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3002259","article-title":"A host-directed oxadiazole compound potentiates antituberculosis treatment via zinc poisoning in human macrophages and in a mouse model of infection","volume":"22","author":"Maure","year":"2024","journal-title":"PLoS Biol."},{"key":"10.1016\/j.ejmech.2025.117935_bib107","doi-asserted-by":"crossref","DOI":"10.3390\/molecules28062529","article-title":"Periphery exploration around 2,6-Diazaspiro[3.4]octane core identifies a potent nitrofuran antitubercular lead","volume":"28","author":"Lukin","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2025.117935_bib108","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.mencom.2022.07.008","article-title":"Hetaryl- and heteroarylvinyl-substituted nitrofurans identified as non-cytotoxic selective antitubercular agents","volume":"32","author":"Krasavin","year":"2022","journal-title":"Mendeleev Commun."},{"key":"10.1016\/j.ejmech.2025.117935_bib109","doi-asserted-by":"crossref","DOI":"10.1007\/s11030-023-10790-9","article-title":"Design, synthesis, anti-mycobacterial activity, molecular docking and ADME analysis of spiroquinoxaline-1,2,4-oxadiazoles via [3 + 2] cycloaddition reaction under ultrasound irradiation","author":"Kanchrana","year":"2024","journal-title":"Mol. Divers."},{"key":"10.1016\/j.ejmech.2025.117935_bib110","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1021\/acsinfecdis.2c00607","article-title":"7-N-Substituted-3-oxadiazole quinolones with potent antimalarial activity target the cytochrome bc1 complex","volume":"9","author":"Nguyen","year":"2023","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.ejmech.2025.117935_bib111","doi-asserted-by":"crossref","first-page":"16695","DOI":"10.1021\/acs.jmedchem.2c01516","article-title":"Novel 3-trifluoromethyl-1,2,4-oxadiazole analogues of astemizole with multi-stage antiplasmodium activity and in vivo efficacy in a Plasmodium berghei mouse malaria infection model","volume":"65","author":"Mambwe","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117935_bib112","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.105492","article-title":"Natural-product-inspired design and synthesis of two series of compounds active against Trypanosoma cruzi: insights into structure-activity relationship, toxicity, and mechanism of action","volume":"119","author":"da Rosa","year":"2022","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.117935_bib113","doi-asserted-by":"crossref","first-page":"11388","DOI":"10.1021\/acs.jmedchem.2c00960","article-title":"Discovery of substituted Di(pyridin-2-yl)-1,2,4-thiadiazol-5-amines as novel macrofilaricidal compounds for the treatment of human filarial infections","volume":"65","author":"Hawryluk","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117935_bib114","article-title":"Design, synthesis and biological activities of 1,2, 4\u2010triazolo [1,5\u2010 a ]pyrimidine\u20107\u2010amine derivatives bearing 1,2, 4\u2010oxadiazole motif","author":"Han","year":"2022","journal-title":"J. Heterocycl. Chem."},{"key":"10.1016\/j.ejmech.2025.117935_bib115","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2023.105654","article-title":"Efficacy of an isoxazole-3-carboxamide analog of pleconaril in mouse models of Enterovirus-D68 and Coxsackie B5","volume":"216","author":"Lane","year":"2023","journal-title":"Antivir. Res."},{"key":"10.1016\/j.ejmech.2025.117935_bib116","doi-asserted-by":"crossref","first-page":"14792","DOI":"10.1021\/acs.jmedchem.2c01311","article-title":"Discovery and optimization of quinoline analogues as novel potent antivirals against Enterovirus D68","volume":"65","author":"Li","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117935_bib117","article-title":"Synthesis and anti-HIV activity of a new isoxazole containing disubstituted 1, 2, 4-oxadiazoles analogs","volume":"56","author":"Kushwaha","year":"2022","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117935_bib118","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114833","article-title":"Discovery of benzimidazole substituted 1, 2, 4-oxadiazole compounds as novel anti-HBV agents with TLR8-agonistic activities","volume":"244","author":"Qiu","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117935_bib119","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27031052","article-title":"Synthesis, Strucure-Activity relationships, and antiviral profiling of 1-Heteroaryl-2-Alkoxyphenyl analogs as inhibitors of SARS-CoV-2 replication","volume":"27","author":"Bardiot","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2025.117935_bib120","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115272","article-title":"Repurposing 1,2,4-oxadiazoles as SARS-CoV-2 PLpro inhibitors and investigation of their possible viral entry blockade potential","volume":"252","author":"Ayoup","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117935_bib121","doi-asserted-by":"crossref","first-page":"10211","DOI":"10.1021\/acs.jmedchem.4c00534","article-title":"Design, synthesis, and biological evaluation of 1,2,4-Oxadiazole derivatives containing an aryl carboxylic acid moiety as potent sarbecovirus papain-like protease inhibitors","volume":"67","author":"Qin","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117935_bib122","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1007\/s12272-022-01380-8","article-title":"Discovery and synthesis of 1,2,4-oxadiazole derivatives as novel inhibitors of Zika, dengue, Japanese encephalitis, and classical swine fever virus infections","volume":"45","author":"Nam","year":"2022","journal-title":"Arch Pharm. Res. (Seoul)"},{"key":"10.1016\/j.ejmech.2025.117935_bib123","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2021.128465","article-title":"Novel O-acylated amidoximes and substituted 1,2,4-oxadiazoles synthesised from (+)-ketopinic acid possessing potent virus-inhibiting activity against phylogenetically distinct influenza A viruses","volume":"55","author":"Chernyshov","year":"2022","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2025.117935_bib124","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1007\/s11030-021-10340-1","article-title":"Design, synthesis and molecular docking studies of some 1-(5-(2-fluoro-5-(trifluoromethoxy)phenyl)-1,2,4-oxadiazol-3-yl)piperazine derivatives as potential anti-inflammatory agents","volume":"26","author":"Kulkarni","year":"2022","journal-title":"Mol. Divers."},{"key":"10.1016\/j.ejmech.2025.117935_bib125","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115417","article-title":"Design, synthesis, and SAR study of novel flavone 1,2,4-oxadiazole derivatives with anti-inflammatory activities for the treatment of Parkinson's disease","volume":"255","author":"Shen","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117935_bib126","doi-asserted-by":"crossref","first-page":"5029","DOI":"10.1021\/acs.jmedchem.1c02210","article-title":"Target fishing reveals a novel mechanism of 1,2,4-Oxadiazole derivatives targeting Rpn6, a subunit of 26S proteasome","volume":"65","author":"Dai","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117935_bib127","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2022.116936","article-title":"Design, synthesis and in vitro biological evaluation of marine phidianidine derivatives as potential anti-inflammatory agents","volume":"71","author":"Xu","year":"2022","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117935_bib128","doi-asserted-by":"crossref","DOI":"10.1002\/cmdc.202200137","article-title":"Discovery and optimization of piperazine urea derivatives as soluble epoxide hydrolase (sEH) inhibitors","volume":"17","author":"\u00c7apan","year":"2022","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2025.117935_bib129","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114806","article-title":"Design, synthesis and evaluation of fused hybrids with acetylcholinesterase inhibiting and Nrf2 activating functions for Alzheimer's disease","volume":"244","author":"Wang","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117935_bib130","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113973","article-title":"Design, synthesis, and biological evaluation of novel (4-(1,2,4-oxadiazol-5-yl)phenyl)-2-aminoacetamide derivatives as multifunctional agents for the treatment of Alzheimer's disease","volume":"227","author":"Liu","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117935_bib131","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1039\/D4MD00113C","article-title":"Design, synthesis, and biological evaluation of 1,2,4-oxadiazole-based derivatives as multitarget anti-alzheimer agents","volume":"15","author":"Ayoup","year":"2024","journal-title":"RSC Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117935_bib132","doi-asserted-by":"crossref","first-page":"12445","DOI":"10.1021\/acs.jmedchem.2c01149","article-title":"Developing HDAC4-Selective protein degraders to investigate the role of HDAC4 in Huntington's disease pathology","volume":"65","author":"Macabuag","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117935_bib133","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1021\/acs.jmedchem.1c00926","article-title":"Discovery and preclinical characterization of BIIB091, a reversible, selective BTK inhibitor for the treatment of multiple sclerosis","volume":"65","author":"Hopkins","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117935_bib134","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2023.136708","article-title":"Design, synthesis, molecular docking, ADMET studies, and biological activity evaluation of new 2-([3-aryl-1,2,4-oxadiazol-5-yl)methyl]thio-1H-benzimidazoles and 6-amino-6-aryl-5,6-dihydro[1,6,2,4]oxathiadiazocino[4,5-a]benzimidazol-3(2H)-ones","volume":"1295","author":"Sharaf","year":"2024","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.ejmech.2025.117935_bib135","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.1021\/acs.jmedchem.2c01643","article-title":"Discovery of novel N-Hydroxy-1,2,4-oxadiazole-5-formamides as ASM direct inhibitors for the treatment of atherosclerosis","volume":"66","author":"Yang","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117935_bib136","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.105606","article-title":"Design, synthesis and biological evaluation of marine phidianidine-inspired derivatives against oxidized ldl-induced endothelial injury by activating Nrf2 anti-oxidation pathway","volume":"120","author":"Xie","year":"2022","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.117935_bib137","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2021.116587","article-title":"Discovery and mechanistic study of thiazole-4-acylsulfonamide derivatives as potent and orally active ChemR23 inhibitors with a long-acting effect in cynomolgus monkeys","volume":"56","author":"Imaizumi","year":"2022","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117935_bib138","doi-asserted-by":"crossref","first-page":"11533","DOI":"10.1021\/acs.jmedchem.2c00676","article-title":"Design, synthesis, and pharmacological evaluation of benzimidazolo-thiazoles as potent CXCR3 antagonists with therapeutic potential in autoimmune diseases: discovery of ACT-672125","volume":"65","author":"Caroff","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117935_bib139","doi-asserted-by":"crossref","first-page":"104","DOI":"10.2174\/1570161117666190405165911","article-title":"The growing epidemic of diabetes mellitus","volume":"18","author":"Lovic","year":"2020","journal-title":"Curr. Vasc. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.117935_bib140","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1177\/2047487319881021","article-title":"The global epidemics of diabetes in the 21st century: current situation and perspectives","volume":"26","author":"Standl","year":"2019","journal-title":"Eur. J. Prev. Cardiol."},{"key":"10.1016\/j.ejmech.2025.117935_bib141","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115584","article-title":"Discovery of orally active sulfonylphenyl thieno[3,2-d]pyrimidine derivatives as GPR119 agonists","volume":"258","author":"Kim","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117935_bib142","doi-asserted-by":"crossref","first-page":"5449","DOI":"10.1021\/acs.jmedchem.1c01842","article-title":"Discovery of V-0219: a small-molecule positive allosteric modulator of the glucagon-like Peptide-1 receptor toward oral treatment for \u201cDiabesity\u201d","volume":"65","author":"Decara","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117935_bib143","doi-asserted-by":"crossref","first-page":"8948","DOI":"10.1021\/acs.jmedchem.2c00165","article-title":"Discovery of BMS-986339, a pharmacologically differentiated farnesoid X receptor agonist for the treatment of nonalcoholic steatohepatitis","volume":"65","author":"Nara","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117935_bib144","doi-asserted-by":"crossref","first-page":"3287","DOI":"10.1021\/acs.jmedchem.3c02121","article-title":"Discovery of TRPA1 antagonist GDC-6599: derisking preclinical toxicity and aldehyde oxidase metabolism with a potential first-in-class therapy for respiratory disease","volume":"67","author":"Terrett","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117935_bib145","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232314942","article-title":"1,2,3-Triazole derivatives as novel antifibrinolytic drugs","volume":"23","author":"Bosch-Sanz","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.ejmech.2025.117935_bib146","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/S0223-5234(99)00218-4","article-title":"QSAR study on antibacterial and antifungal activities of some 3,4-disubstituted-1,2,4-oxa(thia)-diazole-5(4 H)-ones(thiones) using physicochemical, quantumchemical and structural parameters","volume":"34","author":"Geban","year":"1999","journal-title":"Eur. J. Med. Chem."},{"issue":"5","key":"10.1016\/j.ejmech.2025.117935_bib147","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/j.electacta.2009.10.048","article-title":"Ac impedance, X-ray photoelectron spectroscopy and density functional theory studies of 3,5-bis(n-pyridyl)-1,2,4-oxadiazoles as efficient corrosion inhibitors for carbon steel surface in hydrochloric acid solution","volume":"55","author":"Outirite","year":"2010","journal-title":"Electrochim. Acta"},{"issue":"1","key":"10.1016\/j.ejmech.2025.117935_bib148","doi-asserted-by":"crossref","first-page":"15","DOI":"10.4155\/fmc.10.278","article-title":"Qsar analysis of [(Biphenyloxy)Propyl]Isoxazoles: agents against coxsackievirus B3","volume":"3","author":"Muratov","year":"2011","journal-title":"Future Med. Chem."},{"issue":"Issue 9","key":"10.1016\/j.ejmech.2025.117935_bib149","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1166\/jctn.2015.3999","article-title":"Structure\u2013activity relationships andQuantitative structure\u2013activity relationships modeling of some 3-(aryl)-N-(aryl)-1,2,4-Oxadiazol-5-Amine derivatives as anti-proliferative agent","volume":"12","author":"Belaidi","year":"2015","journal-title":"J. Comput. Theor. Nanosci."},{"issue":"33","key":"10.1016\/j.ejmech.2025.117935_bib150","doi-asserted-by":"crossref","first-page":"5072","DOI":"10.2174\/1381612822666160621094009","article-title":"Common SAR derived from multiple QSAR models on vorinostat derivatives targeting HDACs in tumor treatment","volume":"22","author":"Praseetha","year":"2016","journal-title":"Curr. Pharm. Des."},{"issue":"2","key":"10.1016\/j.ejmech.2025.117935_bib151","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1039\/D0MD00305K","article-title":"A second generation of 1,2,4-oxadiazole derivatives with enhanced solubility for inhibition of 3-hydroxykynurenine transaminase (HKT) from Aedes aegypti","volume":"12","author":"Maciel","year":"2021","journal-title":"RSC Med. Chem."},{"issue":"1","key":"10.1016\/j.ejmech.2025.117935_bib152","first-page":"373","article-title":"Discovery of novel 1,2,4-Oxadiazole derivatives as potent Caspase-3 activator for cancer treatment","volume":"3","author":"Vaidya","year":"2021","journal-title":"Chemistry (Switzerland)"},{"issue":"3","key":"10.1016\/j.ejmech.2025.117935_bib153","first-page":"333","article-title":"Enhanced larvicidal activity of new 1,2,4-Oxadiazoles against Aedes aegypti mosquitos: QSAR and docking studies","volume":"34","author":"da Silva","year":"2023","journal-title":"J. Braz. Chem. Soc."},{"issue":"22","key":"10.1016\/j.ejmech.2025.117935_bib154","doi-asserted-by":"crossref","first-page":"12978","DOI":"10.1080\/07391102.2023.2171131","article-title":"Insight parameter drug design for human \u03b2-tryptase inhibition integrated molecular docking, QSAR, molecular dynamics simulation, and pharmacophore modelling studies of \u03b1-keto-[1,2,4]-oxadiazoles","volume":"41","author":"Yu","year":"2023","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"3","key":"10.1016\/j.ejmech.2025.117935_bib155","doi-asserted-by":"crossref","DOI":"10.1002\/cbdv.202402020","article-title":"Synthesis and evaluation of 3,5-Disubstituted-1,2,4-Oxadiazolyl benzamides as potential anti-breast cancer agents: in vitro and in silico studies","volume":"22","author":"Asad","year":"2025","journal-title":"Chem. Biodivers."},{"issue":"1","key":"10.1016\/j.ejmech.2025.117935_bib156","first-page":"167","article-title":"Three-dimensional QSAR analysis and design of new 1,2,4-oxadiazole antibacterials","volume":"26","author":"Leemans","year":"2016","journal-title":"Bioorg. Med. Chem. Lett"},{"issue":"1","key":"10.1016\/j.ejmech.2025.117935_bib157","first-page":"1924","article-title":"3D-QSAR studies of 1,2,4-Oxadiazole derivatives as sortase A inhibitors","volume":"36","author":"Shakour","year":"2021","journal-title":"BioMed Res. Int."},{"issue":"6","key":"10.1016\/j.ejmech.2025.117935_bib158","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1016\/j.bmc.2012.01.032","article-title":"Synthesis and biological validation of novel pyrazole derivatives with anticancer activity guided by 3D-QSAR analysis","volume":"20","author":"Vujasinovi\u0107","year":"2012","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117935_bib159","doi-asserted-by":"crossref","first-page":"S3936","DOI":"10.1016\/j.arabjc.2014.05.034","article-title":"CoMFA, CoMSIA, kNN MFA and docking studies of 1,2,4-oxadiazole derivatives as potent caspase-3 activators","volume":"10","author":"Vaidya","year":"2017","journal-title":"Arab. J. Chem."},{"issue":"3","key":"10.1016\/j.ejmech.2025.117935_bib160","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s00706-020-02553-1","volume":"151","author":"Vaidya","year":"2020","journal-title":"Monatshefte fur Chemie"},{"issue":"1","key":"10.1016\/j.ejmech.2025.117935_bib161","doi-asserted-by":"crossref","first-page":"55","DOI":"10.2174\/1573409914666181015150731","article-title":"Molecular docking analysis of Caspase-3 activators as potential anticancer agents","volume":"15","author":"Kashaw","year":"2019","journal-title":"Curr. Comput. Aided Drug Des."},{"issue":"1","key":"10.1016\/j.ejmech.2025.117935_bib162","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1080\/00397911.2023.2282599","article-title":"Design, synthesis, anticancer evaluation and molecular docking studies of 1,2,4-oxadiazole incorporated indazole-isoxazole derivatives","volume":"54","author":"Lingam","year":"2024","journal-title":"Synth. Commun."},{"key":"10.1016\/j.ejmech.2025.117935_bib163","doi-asserted-by":"crossref","first-page":"373","DOI":"10.3390\/chemistry3010027","article-title":"Discovery of novel 1,2,4-Oxadiazole derivatives as potent Caspase-3 activator for cancer treatment","volume":"3","author":"Vaidya","year":"2021","journal-title":"Chemistry"},{"issue":"1","key":"10.1016\/j.ejmech.2025.117935_bib164","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s13065-024-01235-x","article-title":"New 1,2,4-oxadiazole derivatives as potential multifunctional agents for the treatment of Alzheimer's disease: design, synthesis, and biological evaluation","volume":"18","author":"Ayoup","year":"2024","journal-title":"BMC Chem."},{"key":"10.1016\/j.ejmech.2025.117935_bib165","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1007\/s00044-024-03316-x","article-title":"Synthesis, enzyme inhibition and molecular docking studies of novel 1,2,4-oxadiazole thioether derivatives","volume":"33","author":"Ar\u0131kan \u00d6lmez","year":"2024","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ejmech.2025.117935_bib166","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.ejmech.2016.06.048","article-title":"Exploring the readthrough of nonsense mutations by non-acidic Ataluren analogues selected by ligand-based virtual screening","volume":"122","author":"Pibiri","year":"2016","journal-title":"Eur. J. Med. Chem."},{"issue":"16","key":"10.1016\/j.ejmech.2025.117935_bib167","doi-asserted-by":"crossref","first-page":"11464","DOI":"10.1021\/acs.jmedchem.3c00960","article-title":"Discovery of small-molecule TIM-3 inhibitors for acute myeloid leukemia using pharmacophore-based virtual screening","volume":"66","author":"Abdel-Rahman","year":"2023","journal-title":"J. Med. Chem."},{"issue":"5","key":"10.1016\/j.ejmech.2025.117935_bib168","doi-asserted-by":"crossref","DOI":"10.1002\/ddr.22235","article-title":"Discovery of 5-(1-benzyl-1H-imidazole-4-yl)-1,2,4-oxadiazole derivatives as novel RIPK1 inhibitors via structure-based virtual screening","volume":"8","author":"Yu","year":"2024","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.ejmech.2025.117935_bib169","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2021.104359","article-title":"Identification of novel compounds against three targets of SARS CoV-2 coronavirus by combined virtual screening and supervised machine learning","volume":"133","author":"Kadioglu","year":"2021","journal-title":"Comput. Biol. Med."},{"issue":"3","key":"10.1016\/j.ejmech.2025.117935_bib170","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1002\/cmdc.201200577","article-title":"Identification of a small-molecule inhibitor of HIV-1 assembly that targets the phosphatidylinositol (4,5)-bisphosphate binding site of the HIV-1 matrix protein","volume":"8","author":"Zentner","year":"2013","journal-title":"ChemMedChem"},{"issue":"3","key":"10.1016\/j.ejmech.2025.117935_bib171","doi-asserted-by":"crossref","first-page":"226","DOI":"10.2174\/157018081303160212110319","article-title":"Substituted 1,2,4-oxodiazoles as potent inhibitors of human 11\u03b2-Hydroxysteroid dehydrogenase type 1 (11\u03b2-HSD1): virtual screening and docking results","volume":"13","author":"Ziolkovskiy","year":"2016","journal-title":"Lett. Drug Des. Discov."},{"issue":"1","key":"10.1016\/j.ejmech.2025.117935_bib172","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2025.e41633","article-title":"Molecular docking and molecular dynamics simulation studies of inhibitor candidates against Anopheles gambiae 3-hydroxykynurenine transaminase and implications on vector control","volume":"11","author":"Adedeji","year":"2025","journal-title":"Heliyon"},{"issue":"4","key":"10.1016\/j.ejmech.2025.117935_bib173","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.bmc.2012.12.006","article-title":"Larvicidal isoxazoles: synthesis and their effective susceptibility towards Aedes aegypti larvae","volume":"21","author":"da Silva-Alves","year":"2013","journal-title":"Bioorg. Med. Chem."},{"issue":"3","key":"10.1016\/j.ejmech.2025.117935_bib174","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1021\/acs.jmedchem.7b01254","article-title":"\u03b1-Amino-\u03b2-carboxymuconate-\u03b5-semialdehyde Decarboxylase (ACMSD) Inhibitors as Novel Modulators of De Novo Nicotinamide Adenine Dinucleotide (NAD+) Biosynthesis","volume":"61","author":"Pellicciari","year":"2018","journal-title":"J. Med. Chem."},{"issue":"11","key":"10.1016\/j.ejmech.2025.117935_bib175","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.2174\/1570180819666220610142359","article-title":"1,2,4 triazoles and 1,2,4 oxadiazoles scaffold as SGLT2 inhibitors: molecular docking and ADMET studies","volume":"20","author":"Sharma","year":"2023","journal-title":"Lett. Drug Des. Discov."},{"issue":"7","key":"10.1016\/j.ejmech.2025.117935_bib176","doi-asserted-by":"crossref","first-page":"7751","DOI":"10.1021\/acs.jmedchem.5c00361","article-title":"Development of Diphenyl-1,2,4-Oxadiazole analogues as allosteric modulators of the RXFP3 receptor: evaluation of importance of the N-Substituted-2-Pyrrolidone moiety in RLX-33","volume":"68","author":"Guan","year":"2025","journal-title":"J. Med. Chem."},{"issue":"8","key":"10.1016\/j.ejmech.2025.117935_bib177","doi-asserted-by":"crossref","first-page":"5504","DOI":"10.1080\/10406638.2023.2265027","article-title":"Design and synthesis of some new Quinoxaline-1,2,4-Oxadiazole-Amide conjugates as EGFR targeting agents and ADMET studies","volume":"44","author":"Kurma","year":"2024","journal-title":"Polycycl. Aromat. Compd."},{"issue":"3","key":"10.1016\/j.ejmech.2025.117935_bib178","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1134\/S1068162023030093","article-title":"Synthesis of 5-Aryl-3-((Quinolin-8-ylsulfonyl)methyl)-1,2,4-Oxadiazoles: EGFR-targeting anticancer agents and in silico studies","volume":"49","author":"Chirra","year":"2023","journal-title":"Russ. J. Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.117935_bib179","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.ejmech.2016.12.016","article-title":"Synthesis and biological screening of novel 2-morpholinoquinoline nucleus clubbed with 1,2,4-oxadiazole motifs","volume":"126","author":"Karad","year":"2017","journal-title":"Eur. J. Med. Chem."},{"issue":"7","key":"10.1016\/j.ejmech.2025.117935_bib180","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1021\/acsmedchemlett.8b00134","article-title":"3-Aryl-1,2,4-oxadiazole derivatives active against human rhinovirus","volume":"9","author":"Kim","year":"2018","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2025.117935_bib181","doi-asserted-by":"crossref","DOI":"10.1016\/j.molbiopara.2025.111674","article-title":"In silico and in vitro assessment of anti-leishmania infantum activity of a novel cyclohexyl-1,2,4-oxadiazole derivative","volume":"262","author":"Pinheiro","year":"2025","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.ejmech.2025.117935_bib182","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2023.136724","article-title":"DFT computational studies, spectroscopic (UV\u2013Vis, IR, NMR), in silico molecular docking and ADME study of 3-(3-Methylpyridin-2-yl)-5-phenyl-1,2,4-oxadiazole","volume":"1296","author":"Waghchaure","year":"2024","journal-title":"J. Mol. Struct."},{"issue":"4","key":"10.1016\/j.ejmech.2025.117935_bib183","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.1021\/acs.jmedchem.2c01643","article-title":"Discovery of novel N-Hydroxy-1,2,4-oxadiazole-5-formamides as ASM direct inhibitors for the treatment of atherosclerosis","volume":"66","author":"Yang","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117935_bib184","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/j.ejmech.2018.08.071","article-title":"Structure-activity and structure-property relationships of novel Nrf2 activators with a 1,2,4-oxadiazole core and their therapeutic effects on acetaminophen (APAP)-induced acute liver injury","volume":"157","author":"Xu","year":"2018","journal-title":"Eur. J. Med. Chem."},{"issue":"1","key":"10.1016\/j.ejmech.2025.117935_bib185","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1080\/14756366.2022.2115036","article-title":"Research progress on the synthesis and pharmacology of 1,3,4-oxadiazole and 1,2,4-oxadiazole derivatives: a mini review","volume":"37","author":"Wang","year":"2022","journal-title":"J. Enzym. Inhib. Med. Chem."},{"issue":"11","key":"10.1016\/j.ejmech.2025.117935_bib186","first-page":"1216","article-title":"DFT analysis, ADME, antibacterial activity and molecular docking studies of 2 -(3-aryl-1,2,4-oxadiazol-5-yl)-n-phenylacetamide derivatives","volume":"61","author":"Kasula","year":"2022","journal-title":"Indian J. Chem."},{"issue":"2","key":"10.1016\/j.ejmech.2025.117935_bib187","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s12639-021-01455-1","article-title":"Anti-Leishmania infantum in vitro effect of n-cyclohexyl-1,2,4-oxadiazole and its ADME\/TOX parameters","volume":"46","author":"Pinheiro","year":"2022","journal-title":"J. Parasit. Dis."},{"key":"10.1016\/j.ejmech.2025.117935_bib188","doi-asserted-by":"crossref","first-page":"479","DOI":"10.2147\/OTT.S357765","article-title":"Identification of 1,2,4-Oxadiazoles-Based novel EGFR inhibitors: molecular dynamics simulation-guided identification and in vitro ADME studies","volume":"15","author":"Unadkat","year":"2022","journal-title":"OncoTargets Ther."},{"key":"10.1016\/j.ejmech.2025.117935_bib189","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2023.117487","article-title":"Design, synthesis, and biological evaluation of a novel series of 1,2,4-oxadiazole inhibitors of SLACK potassium channels: identification of in vitro tool VU0935685","volume":"95","author":"Qunies","year":"2023","journal-title":"Bioorg. Med. Chem."},{"issue":"6","key":"10.1016\/j.ejmech.2025.117935_bib190","doi-asserted-by":"crossref","first-page":"2840","DOI":"10.3390\/molecules28062840","article-title":"Expanding the library of 1,2,4-Oxadiazole derivatives: discovery of new Farnesoid X receptor (FXR) antagonists\/pregnane X receptor (PXR) agonists","volume":"28","author":"Finamore","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2025.117935_bib191","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1002\/cjoc.202200392","article-title":"Design, synthesis and biological evaluation of potent and selective S1PR1 agonists for the treatment of ulcerative colitis","volume":"40","author":"He","year":"2022","journal-title":"Chin. J. Chem."},{"issue":"124","key":"10.1016\/j.ejmech.2025.117935_bib192","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/j.ejmech.2016.10.029","article-title":"Heterocyclic replacements for benzene: maximising ADME benefits by considering individual ring isomers","author":"Ritchie","year":"2016","journal-title":"Eur. J. Med. Chem."},{"issue":"21","key":"10.1016\/j.ejmech.2025.117935_bib193","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.drudis.2009.07.014","article-title":"The impact of aromatic ring count on compound developability \u2013 are too many aromatic rings a liability in drug design?","volume":"14","author":"Ritchie","year":"2009","journal-title":"Drug Discov. Today"},{"issue":"3","key":"10.1016\/j.ejmech.2025.117935_bib194","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.drudis.2010.11.014","article-title":"The impact of aromatic ring count on compound developability: further insights by examining carbo- and hetero-aromatic and -aliphatic ring types","volume":"16","author":"Ritchie","year":"2011","journal-title":"Drug Discov. Today"},{"issue":"21","key":"10.1016\/j.ejmech.2025.117935_bib195","doi-asserted-by":"crossref","first-page":"6752","DOI":"10.1021\/jm901241e","article-title":"Escape from flatland: increasing saturation as an approach to improving clinical success","volume":"52","author":"Lovering","year":"2009","journal-title":"J. Med. Chem."},{"issue":"4","key":"10.1016\/j.ejmech.2025.117935_bib196","first-page":"515","article-title":"Escape from flatland 2: complexity and promiscuity","volume":"19","author":"Lovering","year":"2012","journal-title":"Med. Chem. Commun."},{"issue":"3","key":"10.1016\/j.ejmech.2025.117935_bib197","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1038\/s41570-025-00688-5","article-title":"Return to flatland","volume":"9","author":"Churcher","year":"2025","journal-title":"Nat. Rev. Chem"},{"key":"10.1016\/j.ejmech.2025.117935_bib198","unstructured":"Bull R, Van Den Heuve M, James R, Mete A, Nadin A, Ray N. Nitrogen containing heterocyclic compounds useful as m3-receptor modulators. WO2008023157A1."},{"key":"10.1016\/j.ejmech.2025.117935_bib199","unstructured":"Edwards C, Kindon N, Ray N, Sutton J, Alcaraz L. Nitrogen containing hetrocyclic compounds useful as bifunctional modulators of m3 receptors and beta- 2 receptors. WO2008096129."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425007007?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425007007?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T05:01:53Z","timestamp":1776920513000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523425007007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":199,"alternative-id":["S0223523425007007"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.117935","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"1,2,4-Oxadiazoles in medicinal chemistry: trends of the last years","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.117935","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"117935"}}